# Ketamine Co-induction for Patients With Major Depressive Disorder

> **NCT03666494** · PHASE4 · UNKNOWN · sponsor: **University of Saskatchewan** · enrollment: 50 (estimated)

## Conditions studied

- Ketamine
- Depression
- Anesthesia

## Interventions

- **DRUG:** Ketamine Hydrochloride
- **DRUG:** Propofol
- **DRUG:** Fentanyl

## Key facts

- **NCT ID:** NCT03666494
- **Lead sponsor:** University of Saskatchewan
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-12
- **Primary completion:** 2019-12
- **Final completion:** 2019-12
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2018-09-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03666494

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03666494, "Ketamine Co-induction for Patients With Major Depressive Disorder". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03666494. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*